3 Under-$50 Canadian Stocks to Buy for Superior Long-Term Returns

Given their solid financials and healthy growth prospects, these three under-$50 Canadian stocks are ideal for long-term investors.

Investing in equity markets is an excellent means to build wealth over the long term. You don’t require huge capital to start your investment journey. Making small but regular investments in quality stocks can create substantial wealth over the long term. Let’s look at three stocks with healthy long-term growth potential that you can buy with just $50.

Source: Getty Images

Savaria

Savaria (TSX: SIS) is one of my top picks due to its solid financial performance and healthy growth prospects. The accessibility solutions provider posted a healthy first-quarter performance last month, with its top line growing by 5.2% amid favourable currency translation and organic growth. Its adjusted EBITDA (earnings before interest, tax, depreciation, and amortization) rose 17.2% to $40.6 million, while its adjusted EBITDA margin expanded from 190 basis points to 18.5%.

The company also strengthened its financial position, with its net debt-to-adjusted EBITDA improving from 1.63 to 1.49. It also ended the quarter with $254.7 million of available funds, therefore well-equipped to fund its capital investments and growth opportunities.

Moreover, the aging population and rising income levels continue to drive the demand for accessibility solutions. Given its innovative product launches, widespread manufacturing facilities, and solid dealer network, Savaria is well-positioned to benefit from the expanding addressable market. Additionally, the adoption of its “Savaria One” initiative has led to structural improvements, strengthening of its production capacity, and enhanced operational efficiencies. Notably, the company also pays monthly dividends, with its forward yield at 2.83%. Considering all these factors, I expect Savaria to deliver superior returns over the next five years.

Docebo

Another under-$50 Canadian stock that I am bullish on is Docebo (TSX: DCBO), which offers scalable and personalized learning programs through its end-to-end learning platform. The company had posted an impressive first-quarter performance last month, beating its revenue and profitability guidance. Its top line grew 11.5% to $57.3 million amid strong performance from its subscription segment.

The company posted a net income of $1.5 million during the quarter. However, removing one-time or extraordinary expenses, its adjusted net income stood at $8.5 million, translating into an adjusted EPS (earnings per share) of $0.28. Its adjusted EPS represents a 16.7% increase from the previous year’s quarter. It also generated $9 million of free cash flow during the quarter, accounting for 15.6% of the company’s total revenue.

The LMS (Learning Management System) market is expanding amid rising remote working, technological developments, and its cost-effectiveness and scalability. Meanwhile, Docebo is focusing on innovation and has launched several artificial intelligence-powered products, which could strengthen its position. Additionally, its expanding customer base and growing average contract value are likely to support its financial growth in the years to come. Meanwhile, amid the recent weakness, the company has lost over 40% of its stock value this year, with its NTM (next 12 months) price-to-earnings multiple falling to 22.9, making it an excellent buy.

WELL Health Technologies

My final pick is WELL Health Technologies (TSX: WELL), a tech-enabled healthcare company that facilitates healthcare professionals to deliver positive patient outcomes. The digitization of clinical procedures and the increased adoption of telehealthcare services have created a multi-year growth potential. Amid the expanding addressable market, the company continues to launch innovative products to grow its market share. It has recently partnered with WovenX Health to deliver integrated, next-generation gastroenterology practice solutions.

Along with these growth initiatives, WELL Health is also focusing on inorganic growth and has signed 11 letters of intent. These acquisitions can contribute $65 million to its annualized revenue. Additionally, the company initiated a share-repurchase plan last month, with plans to repurchase 6.33 million shares over the next 12 months, thereby reducing its outstanding shares by 2.5%. Considering all these factors, I believe WELL Health would be an excellent long-term buy.

Fool contributor Rajiv Nanjapla has no position in any of the stocks mentioned. The Motley Fool recommends Docebo. The Motley Fool has a disclosure policy.

More on Investing

A family watches tv using Roku at home.
Dividend Stocks

Forget Telus Stock: A Dividend Giant I’d Buy Immediately Instead

Telus cut its dividend, and its cash flow is falling. Rogers just posted record free cash flow and held its…

Read more »

stocks climbing green bull market
Dividend Stocks

In a Few Years, You’ll Probably Regret Not Owning TMX Stock

TMX Group is a quality business, demonstrating growth potential from multiple sources. It's a top candidate for long-term holding.

Read more »

Business doodle about dividends on chalkboard
Dividend Stocks

How Much to Invest in Enbridge for $1,000 a Year in Dividends

Given its resilient business model, predictable cash flows, consistent dividend growth, high yield, and healthy growth prospects, Enbridge would be…

Read more »

happy woman throws cash
Dividend Stocks

1 Way to Use a TFSA to Earn $250 in Monthly Income

Uncover the potential of a TFSA for generating income. Reinvest and withdraw your funds effortlessly without tax concerns.

Read more »

Blocks conceptualizing Canada's Tax Free Savings Account
Dividend Stocks

A Simple TFSA Strategy for $250 in Monthly Tax-Free Income

These Canadian stocks offer monthly dividend payments and have a solid history of payouts across all market conditions while offering…

Read more »

coins jump into piggy bank
Dividend Stocks

A Dividend Giant I’d Buy over Telus Stock Right Now

This dividend giant has a solid history of rewarding shareholders and is well-positioned to grow its distributions year after year.

Read more »

Hourglass and stock price chart
Energy Stocks

Pembina vs. TC Energy: Which Pipeline Stock Would I Buy for the Next Decade?

I’d choose TC Energy for its natural gas focus over the next decade. Pembina has a case of its own…

Read more »

Start line on the highway
Dividend Stocks

2 Simple Canadian Stocks to Buy With $1,000

Looking for Canadian stocks to buy with $1,000? Explore Enbridge and Scotiabank for dividend income and a straightforward long-term starting…

Read more »